Gerresheimer starts the year successfully in 2008

 * Sales increase by 18.2% to €239.1m in the first quarter of 2008  * Operating result (Adjusted EBITDA) improves by 20.4% to €43.0m  * Integration of the acquisitions EDP and Allplas progressing in line with plan  * CEO Dr.

Axel Herberg: “We have again substantially increased our sales and earnings, and results are fully in line with our forecasts.”

Düsseldorf, 14 April 2008 – Gerresheimer AG has started the financial year 2008 with an outstanding first quarter. Sales grew by 18.2% compared with the prior year period to €239.1m (2007: €202.3m). Excluding exchange-rate effects, sales actually rose by 21.8%. The operating result (Adjusted EBITDA) also improved again, increasing by 20.4% to €43.0m (prior year period: €35.7m). The Adjusted EBITDA margin therefore reached 18.0% in the first quarter (December 2007 – February 2008), which is seasonally the weakest quarter over the course of the year. The adjusted net income, which shows the operating strength of the company, almost quadrupled to €9.9m (prior year period: €2.6m). The net income improved by €6.5m to €2.5m (prior year period: €-4.0m). Overall, Gerresheimer profited primarily from the high level of demand in the pharma and life science segment, where the company achieves three quarters of its total sales.

“The first quarter was extremely successful for us. We improved our results in all divisions and are therefore well ahead of the overall market development. Gerresheimer is outstandingly well positioned and we are well on the way to achieving our ambitious targets for the current financial year”, says Dr. Axel Herberg, CEO of Gerresheimer AG.

Successful development of all divisions

All the divisions contributed to the positive development of the Group. In addition to the sustained high level of demand for Gerresheimer products, this was attributable to the successful integration of the acquisitions made.

In the first quarter of 2008, sales in the Tubular Glass Division increased by 9.1%, or 14.6% on a like-for-like exchange-rate basis, to €65.7m (prior year period: €60.2m). Adjusted EBITDA totalled €15.7m (prior year period: €15.0m). The main growth generator in this division was the 68% increase in sales of RTF (Ready-to-Fill) syringes. To meet this sustained high level of demand, Gerresheimer plans to install a third RTF production line at the start of 2009. Further growth contributors were the rise in sales of pharmaceutical vials in the American market and growth in China.

Sales by the Plastic Systems Division increased by 37.1% to €77.2m (prior year period: €56.3m). Adjusted EBITDA actually rose by 45.4% to €14.1m (prior year period: €9.7m). This division profited from the rise in demand for inhalers and products for the segment of diabetes care. Also in this division, integration of the companies EDP (today Gerresheimer Zaragoza S.A.) and Allplas (today Gerresheimer Plasticos Sao Paulo Ltda.), which were acquired at the start of 2008, is progressing well.

With sales growth of 5.0 % (7.8% on a like-for-like exchange-rate basis) the Moulded Glass Division considerably exceeded the market average. Adjusted EBITDA on the basis of sales of €77.6m (prior year period: €73.9m) improved by 20.3% to €16.0m. Particular contributions were made by the pharmaceutical vials business in the USA and Europe and increased sales of cosmetics products.

The Life Science Research Division achieved a sales increase of 81.7 % to €21.8m (prior year period: €12.0m) following the expansion of business operations after establishment of the joint venture with Thermo Fisher. The operating result improved to €2.4m (prior year period: €1.3m).

Gerresheimer still on a successful course

“We will continue our successful development in 2008. We have substantially improved the results in all divisions and see this as full confirmation of our strategy. With its products, Gerresheimer is a reliable partner for the pharma & life science industry, which is our core business. We benefit from the growth in this sector and will further expand our good position in the market,” says Dr. Axel Herberg. For the financial year 2008 as a whole, Gerresheimer’s objective is to achieve a sales increase of 13% to 15% and an improvement in the adjusted EBITDA margin to more than 19%.

Click on the link bellow to read the entire article.

600450 Gerresheimer starts the year successfully in 2008 glassonweb.com

See more news about:

Others also read

Machinery and products for glass: Markets on the upswing, excellent exports performance
The Gimav Studies Centre releases official data on the sector: the growth trend continues for the 8th consecutive year.
British Glass members meet with BEIS to discuss Brexit interests and issues
British Glass is today hosting a face-to-face meeting between the Department for Business, Energy and Industrial Strategy (BEIS) and representatives from flat, container and fibre glass manufacturing.
Latest Report on the Window, Door and Facade Industries in China
China now is the largest manufacturer and user of architectural doors and windows and facades in the globe. The number of industry players in the construction industry of doors, windows and facades in China is approximately 6.8 million at present.
Prof. Ahmet Kırman
Şişecam Group reported consolidated net sales of TL 3.1 billion and a net profit of TL 569 million in the first quarter ended March 31, 2018. The Group's consolidated EBITDA reached TL 907 million for the same period.
Bigger and Busier: Windoor Expo 2018 Concluded Successfully with a Total of 64,518 Visitors
Windoor Expo is the ultimate industry event in China connecting architects, builders, contractors, fabricators, real estate developers and traders.
Glaston
Orders received grew 23%, comparable operating profit at previous year’s level.

Add new comment